People

Introduction
People lie at the heart of what we do. Our Philosophy, ‘People come first at Ferring’, is where this commitment starts. This means our patients and their families, healthcare professionals and our employees. We are also guided by Global Compact principles on labour and human rights, which expect of us a commitment to uphold laws and good practice in our business wherever we operate.

For our patients, and the medical communities that support them, we aim to provide professional, medical, training or financial support in therapeutic areas where we can make a difference. For our employees, we seek above all to provide a safe and healthy work environment, to encourage and support their development, and to respect our multi-cultural working cultures across the world.

See more of our People activities.

Our Progress

Developing a Signature Platform focused on maternal health – We are in the process of developing a global signatory CSR platform in an area we believe we can make a transformational difference: maternal health. We have gained support and approval from our senior management and stakeholders for this concept and have a short-list of potential partners. We intend to lay firm foundations for a launch in 2017.

• Towards alignment with the Global Compact Principles on Labour and Human Rights – We have carried out an initial inventory on our policies and practices that relate to labour laws & human rights at our headquarters and with our affiliates. This showed encouraging levels of compliance with relevant laws and regulations. We will now share this information with our compliance and HR organisations globally to see how we can further improve our performance.

 

 Examples of Our Initiatives

Global Corporate Challenge (GCC) – following a suggestion from an employee, Ferring participated in a web-based health programme providing employees with a simple and engaging way to create a true culture of health across the business. Each year, for 100 days, hundreds of thousands of people from different companies around the world compete in teams to reach a collective exercise goal. The GCC takes them on a virtual journey improving both their physical and psychological health. 38 teams at Ferring participated in the challenge. At the end of 100 days they received a final improved lifestyle score. It proved a fun and engaging way to improve both departmental team work and health.

Project CHAMPION (Carbetocin Hemorrhage Prevention Study) – the biggest contributor to maternal mortality globally is PPH which accounted for 480,000 maternal deaths between 2003 2009.¹ Most of these deaths take place in Africa and Asia. Building on our partnership with the WHO and MSD for Mothers, we are undertaking the biggest clinical trial ever undertaken in this therapy area. With 30,000 participants across 10 countries and 23 hospitals, we are carrying out a Phase III trial using heat-stable carbetocin for the prevention of PPH during the 3rd stage of labour in women delivering vaginally. Focusing on countries with the greatest need, we hope that the success of this trial will, in time, make a significant contribution to reaching the UN goal of reducing maternal mortality to under 70 per 100,000 globally by 2030.

Training for obstetric emergencies and perinatal care in the Philippines – At 160 deaths per 100,000 births, maternal mortality in the Philippines remains high, despite government efforts to reduce it. In 2015 Ferring embarked on a three-year commitment to support a programme aimed at reducing maternal mortality arising from post-partum haemorrhage. The project is a collaboration between the authorities in the Philippines and the maternity foundation Practical Obstetric Multi-Professional Training (PROMPT) from the UK. It is carried out under the auspices of Project Hope, an established Ferring NGO partner. The programme will train hospital staff in 7 hospitals across the country to provide a higher quality of care. As of June 2016, all 7 participating hospitals had completed almost 50% of the training programmes.

Baby liver transplants – In China, about 2000 babies a year are born suffering from Biliary Atresia, a childhood disease of the liver. A liver transplant is the only way to save their lives. The surgery is costly, and there is little awareness of and support for the disease. Our China team recognised a need, and launched an employee fund-raising effort, matched 2:1 by the company. The target was RMB300K (40K euros) to support liver transplants for three babies by the end of 2016.

 

¹ Say, L. et al (2014). Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health [online] Vol 2 (6), p. e323–333. Available at: http://www.sciencedirect.com/science/article/pii/S2214109X1470227X [Accessed 2 April, 2017].